Its chemical stability in gastric environments and efficacy across multiple administration routes make it a candidate for further investigation in regenerative pharmacology 2
The research concludes that there is an increased risk of pancreatitis, gastroparesis, and bowel obstruction with the use of the drugs
[19] Los agonistas del receptor GLP-1, como la semaglutida y la liraglutida, suelen causar efectos adversos gastrointestinales como nuseas, vmitos, diarrea, estreimiento y molestias abdominales, especialmente durante el aumento de la dosis
This characteristic supports fat metabolism and provides cognitive benefits, such as improved focus and memory
Unlike GLP-1s, TIX100 did not lead to any loss of lean mass either
The biggest worry is whether the drug moves into breast milk